Horan Capital Advisors LLC. Has $522,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Horan Capital Advisors LLC. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,056 shares of the healthcare conglomerate’s stock after selling 89 shares during the period. Horan Capital Advisors LLC.’s holdings in UnitedHealth Group were worth $522,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the company. Kennedy Capital Management LLC raised its holdings in UnitedHealth Group by 17.7% during the third quarter. Kennedy Capital Management LLC now owns 8,403 shares of the healthcare conglomerate’s stock valued at $4,237,000 after buying an additional 1,266 shares in the last quarter. Royal London Asset Management Ltd. increased its stake in shares of UnitedHealth Group by 6.8% in the third quarter. Royal London Asset Management Ltd. now owns 1,483,842 shares of the healthcare conglomerate’s stock worth $748,242,000 after purchasing an additional 94,826 shares during the period. Cito Capital Group LLC increased its stake in shares of UnitedHealth Group by 3.1% in the third quarter. Cito Capital Group LLC now owns 3,326 shares of the healthcare conglomerate’s stock worth $1,677,000 after purchasing an additional 100 shares during the period. Baker Avenue Asset Management LP increased its stake in shares of UnitedHealth Group by 1.7% in the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares during the period. Finally, Crestwood Advisors Group LLC increased its stake in shares of UnitedHealth Group by 123.7% in the third quarter. Crestwood Advisors Group LLC now owns 2,411 shares of the healthcare conglomerate’s stock worth $1,216,000 after purchasing an additional 1,333 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Piper Sandler boosted their price target on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Finally, Truist Financial restated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Three investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Trading Down 0.4 %

NYSE:UNH traded down $1.88 during trading hours on Friday, hitting $488.01. 3,498,996 shares of the stock were exchanged, compared to its average volume of 4,448,744. The company’s 50 day moving average is $498.46 and its two-hundred day moving average is $500.70. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $449.16 billion, a P/E ratio of 29.83, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter in the prior year, the business earned $6.26 EPS. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a dividend of $2.10 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.72%. UnitedHealth Group’s payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.